Latest Breaking News On - Catherine pachuk - Page 1 : comparemela.com

Published: Dec 23, 2020 MALVERN, Pa., Dec. 23, 2020 (GLOBE NEWSWIRE) Ocugen, Inc., (NASDAQ: OCGN), a leading biopharmaceutical company focused on discovering, developing and commercializing a pipeline of innovative therapies, today announced the appointment of a vaccine scientific advisory board comprised of leading academic and industry experts in the vaccine field to evaluate the clinical and regulatory path to approval in the US market of Bharat Biotech’s COVAXIN™, a whole-virion inactivated COVID-19 vaccine candidate to be co-developed by Ocugen and Bharat Biotech for the US market. Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen remarked, “We are thrilled to welcome this group of esteemed thought leaders to the Ocugen team to assist in our co-development with Bharat Biotech of COVAXIN™. This unique yet traditional vaccine candidate is different from other options currently available in the US market with potentially broader coverage against multip

New yorkUnited statesNorth carolinaSouth africaSan franciscoCatherine pachukDavid fajgenbaumSusan weissLisa descenzaHarold varmusSatish chandranBruce forrestSanjay subramanianShankar musunuriHarvey rubinMike bishop